This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Shenyang Pharmaceutical University, Shenyang Pharmaceutical University (Benxi) Pharmaceutical Science and Technology Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Wufu Zhu: Innovator in Quinoline and Cinnoline Derivatives
Introduction
Wufu Zhu is a notable inventor based in Shenyang, China. He has made significant contributions to the field of medicinal chemistry, particularly through his work on quinoline and cinnoline derivatives. His innovative research focuses on developing compounds that have potential applications in treating diseases associated with abnormal expression of c-Met kinase.
Latest Patents
Wufu Zhu holds a patent for "Quinoline and Cinnoline Derivatives and Their Applications." This invention relates to a series of quinoline and cinnoline derivatives of general formula I, along with their pharmaceutically acceptable salts, hydrates, solvates, or prodrugs. The compounds of general formula I exhibit potent inhibitory activity against c-Met kinase. Furthermore, the invention details the uses of these compounds for preparing medicaments aimed at treating and preventing diseases caused by abnormal c-Met kinase expression, particularly cancer.
Career Highlights
Wufu Zhu has been associated with Shenyang Pharmaceutical University, where he has contributed to various research initiatives. He has also worked with Shenyang Pharmaceutical University (Benxi) Pharmaceutical Science and Technology Co., Ltd., further enhancing his expertise in pharmaceutical sciences.
Collaborations
Wufu Zhu has collaborated with notable colleagues such as Ping Gong and Yanfang Zhao, contributing to advancements in his field through shared knowledge and research efforts.
Conclusion
Wufu Zhu's work in developing quinoline and cinnoline derivatives showcases his commitment to advancing medical science. His innovative contributions have the potential to impact cancer treatment significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile